"Methods Of Imaging And Delivering Therapeutic Agents" in Patent Application Approval Process (USPTO 20230211021).

Keywords: Biotechnology; Chest Pain; Diagnostics and Screening; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Health and Medicine; Hospitals; Nanoparticles; Nanotechnology; Patent Application; Pharmaceuticals; Theranostics; Therapeutics; Therapy EN Biotechnology Chest Pain Diagnostics and Screening Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Health and Medicine Hospitals Nanoparticles Nanotechnology Patent Application Pharmaceuticals Theranostics Therapeutics Therapy 405 405 1 07/24/23 20230724 NES 230724 2023 JUL 27 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- A patent application by the inventors Angel, Brett (Bala Cynwyd, PA, US); Cimorelli, Michael (Turnersville, NJ, US); Fafarman, Aaron (Narberth, PA, US); Kohut, Andrew (Philadelphia, PA, US); Wrenn, Steven P. (Swarthmore, PA, US), filed on August 10, 2022, was made available online on July 6, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. The method of claim 25, wherein the third mixture comprises an aqueous polyvinyl alcohol solution, wherein the concentration of polyvinyl alcohol in the aqueous polyvinyl alcohol solution is about 2 wt %. The method of claim 34, wherein the third mixture comprises an aqueous polyvinyl alcohol solution, wherein the concentration of polyvinyl alcohol in the aqueous polyvinyl alcohol solution is about 2 wt %. In yet other embodiments, the at least one phospholipid comprises at least one phospholipid selected from the group consisting of saturated phospholipid, unsaturated phospholipid, phospholipid charged, and uncharged or zwitterion phospholipid. [Extracted from the article]